Agonists and Antagonists for Purinergic Receptors-Reference-Cited by-同舟云学术

Agonists and Antagonists for Purinergic Receptors

Published:2019-10-24 Issue: Volume: Page:45-64
ISSN:1064-3745
Container-title:Methods in Molecular Biology
language:
Short-container-title:

Author:

Müller Christa E.,Baqi Younis,Namasivayam Vigneshwaran

Publisher

Springer New York

Link

http://link.springer.com/content/pdf/10.1007/978-1-4939-9717-6_3

Reference54 articles.

1. Burnstock G (2007) Purine and pyrimidine receptors. Cell Mol Life Sci 64:1471–1483

2. Fredholm BB, IJzerman AP, Jacobson KA et al (2011) International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors – an update. Pharmacol Rev 63:1–34

3. Abbracchio MP, Burnstock G, Boeynaems JM et al (2006) International Union of Pharmacology. LVIII: Update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 58:281–341

4. Khakh BS, Burnstock G, Kennedy C et al (2001) International Union of Pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol Rev 53:107–118

5. Jacobson KA, Müller CE (2016) Medicinal chemistry of adenosine, P2Y and P2X receptors. Neuropharmacology 104:31–49

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. mitoBKCa is functionally expressed in murine and human breast cancer cells and potentially contributes to metabolic reprogramming;eLife;2024-05-29

2. Cytokine storm in human monkeypox: A possible involvement of purinergic signaling;Cytokine;2024-05

3. mitoBKCa is functionally expressed in murine and human breast cancer cells and potentially contributes to metabolic reprogramming;2024-04-08

4. Adenosine A2B receptor agonist improves epidermal barrier integrity in a murine model of epidermal hyperplasia;Biomedicine & Pharmacotherapy;2024-04

5. Mechanisms of HIV-mediated blood-brain barrier compromise and leukocyte transmigration under the current antiretroviral era;iScience;2024-03